Yes, testosterone cypionate can be injected subcutaneously, and a growing number of clinicians now prescribe it this way. While testosterone cypionate is traditionally labeled for intramuscular (IM) injection, subcutaneous (SubQ) delivery has been studied in clinical settings and is considered a safe, practical alternative. A 2022 review published in The Journal of Clinical Endocrinology and Metabolism called subcutaneous testosterone injection “a safe, practical, and reasonable option.”
Why Subcutaneous Is Gaining Popularity
Intramuscular injections use a longer needle (typically 1 to 1.5 inches) to deliver testosterone deep into muscle tissue, usually the glute or thigh. Subcutaneous injections go into the fat layer just beneath the skin, using a much shorter needle, typically a 25-gauge, 5/8-inch needle. For many people, this makes the injection significantly less intimidating and less painful.
The practical appeal is straightforward: shorter needles, easier self-injection, and more accessible injection sites. Studies have used the abdomen and thigh as subcutaneous sites, both of which are simple to reach without help. This matters because testosterone replacement therapy is a long-term commitment, often involving injections once or twice a week, and comfort with the process directly affects whether people stick with treatment.
How Testosterone Levels Compare
Subcutaneous injection effectively raises testosterone into the normal range, just as intramuscular injection does. But the two routes absorb differently. Intramuscular injections tend to produce a sharp spike in testosterone shortly after the shot, followed by a steady decline until the next dose. Subcutaneous injection generally produces a more gradual absorption curve, meaning less dramatic peaks and troughs.
That flatter curve has real consequences. Intramuscular testosterone cypionate is known to cause significant rises in estradiol (a form of estrogen) and hematocrit (a measure of red blood cell concentration) because of its high testosterone peaks. Research published in The Journal of Urology found that subcutaneous delivery was independently associated with lower post-therapy estradiol and hematocrit levels compared to intramuscular injection, even after adjusting for other variables. Both of those markers matter: elevated estradiol can contribute to water retention and breast tissue changes, while elevated hematocrit increases the risk of blood clots.
What the Injection Looks Like
Clinical studies have used 1-mL syringes with a 25-gauge, 5/8-inch needle for subcutaneous testosterone cypionate. The two most common sites are the lower abdomen (a couple of inches to the side of the belly button) and the outer thigh. You pinch a fold of skin, insert the needle at roughly a 45-degree angle, and inject slowly.
Volume per injection generally stays at or under 1 mL per site. Because subcutaneous tissue doesn’t absorb large volumes as easily as muscle, many prescribers split a weekly dose into two smaller injections. For example, instead of one 200 mg intramuscular injection per week, a provider might prescribe 100 mg subcutaneously twice a week. This split dosing further smooths out the peaks and troughs in testosterone levels, which may help with mood and energy stability between shots.
Some people notice small, temporary lumps or firmness at the injection site. Rotating between the left and right sides of the abdomen and thigh helps minimize this. The lumps typically resolve on their own within a few days.
Is It Officially Approved This Way?
Testosterone cypionate’s FDA-approved labeling specifies intramuscular injection. When a clinician prescribes it subcutaneously, that’s technically off-label use. Off-label doesn’t mean unsafe or unsupported. It means the manufacturer hasn’t sought formal approval for that specific route. In practice, subcutaneous testosterone has been used for years in hormone clinics and endocrinology practices, and the published evidence supports its effectiveness and safety.
A separate product, a subcutaneous testosterone enanthate autoinjector, has received FDA approval specifically for subcutaneous use. Testosterone enanthate is very similar to cypionate in its chemical structure and behavior. The approval of that product reflects broader regulatory acceptance that subcutaneous testosterone delivery works.
Timeline for Feeling Results
Regardless of whether you inject subcutaneously or intramuscularly, the timeline for noticing benefits follows a similar pattern. Improvements in sexual interest and libido typically appear within 3 weeks and plateau around 6 weeks. Effects on depressed mood become noticeable after 3 to 6 weeks, with maximum improvement taking 18 to 30 weeks. This timeline applies to testosterone therapy in general, not to the injection route, so switching from intramuscular to subcutaneous shouldn’t restart the clock if your levels remain stable.
Subcutaneous vs. Intramuscular: Key Differences
- Needle size: SubQ uses a 5/8-inch needle; IM typically uses a 1- to 1.5-inch needle.
- Pain and ease: Most people find SubQ injections less painful and easier to self-administer.
- Testosterone peaks: SubQ tends to produce lower peak levels and a more stable release between doses.
- Estradiol and hematocrit: SubQ is associated with lower spikes in both, reducing certain side effect risks.
- Injection sites: SubQ uses the abdomen or thigh; IM typically uses the glute or outer thigh muscle.
- Volume per site: SubQ works best with 1 mL or less per site, which may require splitting larger doses.
Who It Works Best For
Subcutaneous injection is a good fit for most people on testosterone replacement therapy, particularly those who are uncomfortable with longer needles, prefer self-injecting at home, or want to minimize the peaks and troughs that come with less frequent intramuscular dosing. People who are very lean with minimal body fat may find subcutaneous injection slightly less comfortable, since there’s less tissue to inject into, but this is rarely a barrier.
If your current intramuscular regimen is working well and you’re comfortable with the process, there’s no medical reason you need to switch. But if you’re starting therapy for the first time, or if you dread injection days, subcutaneous delivery offers the same therapeutic benefit with a more manageable experience.